Catherine Tsai is Partner in Taifong Partners’ Taipei office. She is also a Director of GeneReach Biotechnology. Prior to joining Taifong Partners, Catherine Tsai was a Vice-President of Taian Technologies and WI Harper responsible for Healthcare and TMT investments.
 

Previously, Catherine was a Vice-President of FCC Partners, a boutique investment bank focusing on middle-market deals, linking Greater China and the US capital markets.  She handled more than 15 private placement and M&A projects; managed corporate clients in Taiwan and China; acted as advisor to the client by providing financial advisory services, business development services and corporate strategy consulting services. She has also worked for Academia Sinica, the most preeminent academic institution in Taiwan, where she managed national genomics research program and several technology licensing projects.
 

Catherine is experienced in global business management, corporate strategy development, intellectual property management, and corporate finance. 
 

Catherine holds an M.B.A. from Thunderbird School of Global Management (Arizona) and a Master of Intellectual Property Law from Franklin Pierce Law School (New Hampshire).